Androgens in Health and Disease.pdf - E Library
Androgens in Health and Disease.pdf - E Library
Androgens in Health and Disease.pdf - E Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Chapter 16/Androgen Treatment of the Hypogonadal Male 331<br />
REFERENCES<br />
1. Amory JK, Anawalt BD, Paulsen CA, Bremner WJ. Kl<strong>in</strong>efelter’s syndrome. Lancet 2000;356:333–335.<br />
2. Matsumoto AM. The testis. In: Felig P, Frohman LA, eds. Endocr<strong>in</strong>ology <strong>and</strong> Metabolism, 4th Edition.<br />
McGraw-Hill, New York, 2001, pp. 635–705.<br />
3. Bhas<strong>in</strong> S, Storer TW, Asbel-Sethi N, et al. Effects of testosterone replacement with a nongenital,<br />
transdermal system, Androderm, <strong>in</strong> human immunodeficiency virus-<strong>in</strong>fected men with low testosterone<br />
levels. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 1998;83:3155–3162.<br />
4. Gr<strong>in</strong>spoon S, Corcoran C, Askari H, et al. Effects of <strong>and</strong>rogen adm<strong>in</strong>istration <strong>in</strong> men with the AIDS<br />
wast<strong>in</strong>g syndrome. A r<strong>and</strong>omized, double-bl<strong>in</strong>d, placebo-controlled trial. Ann Intern Med 1998;<br />
129:18–26.<br />
5. Gr<strong>in</strong>spoon S, Corcoran C, Stanley T, et al. Effects of hypogonadism <strong>and</strong> testosterone adm<strong>in</strong>istration<br />
on depression <strong>in</strong>dices <strong>in</strong> HIV-<strong>in</strong>fected men. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 2000;85:60–65.<br />
6. H<strong>and</strong>elsman DJ, Liu PY. Androgen therapy <strong>in</strong> chronic renal failure. Baillieres Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab<br />
1998;12:485–500.<br />
7. Matsumoto AM. Andropause: cl<strong>in</strong>ical implications of the decl<strong>in</strong>e <strong>in</strong> serum testosterone levels with<br />
ag<strong>in</strong>g <strong>in</strong> men. J Gerontol A: Biol Sci Med Sci 2002;57:M76–M99.<br />
8. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy <strong>in</strong> glucocorticoid-treated men.<br />
Arch Intern Med 1996;156:1173–1177.<br />
9. Bremner WJ, Vitiello MV, Pr<strong>in</strong>z PN. Loss of circadian rhythmicity <strong>in</strong> blood testosterone levels with<br />
ag<strong>in</strong>g <strong>in</strong> normal men. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 1983;56:1278–1281.<br />
10. Giraudi G, Cenderelli G, Migliardi M. Effect of tracer b<strong>in</strong>d<strong>in</strong>g to serum prote<strong>in</strong>s on the reliability of<br />
a direct free testosterone assay. Steroids 1988;52:423–424.<br />
11. Rosner W. Errors <strong>in</strong> the measurement of plasma free testosterone. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab<br />
1997;82:2014–2015.<br />
12. Rosner W. An extraord<strong>in</strong>arily <strong>in</strong>accurate assay for free testosterone is still with us. J Cl<strong>in</strong> Endocr<strong>in</strong>ol<br />
Metab 2001;86:2903.<br />
13. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation<br />
of free testosterone <strong>in</strong> serum. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 1999;84:3666–3672.<br />
14. W<strong>in</strong>ters SJ, Kelley DE, Goodpaster B. The analog free testosterone assay: are the results <strong>in</strong> men<br />
cl<strong>in</strong>ically useful? Cl<strong>in</strong> Chem 1998;44:2178–2182.<br />
15. Spratt DI, O’Dea LS, Schoenfeld D, et al. Neuroendocr<strong>in</strong>e-gonadal axis <strong>in</strong> men: frequent sampl<strong>in</strong>g of<br />
LH, FSH, <strong>and</strong> testosterone. Am J Physiol 1988;254:E658–E666.<br />
16. Matsumoto AM. Cl<strong>in</strong>ical use <strong>and</strong> abuse of <strong>and</strong>rogens <strong>and</strong> anti<strong>and</strong>rogens. In: Becker KL, ed. Pr<strong>in</strong>ciples<br />
<strong>and</strong> Practice of Endocr<strong>in</strong>ology <strong>and</strong> Metabolism, 3rd Edition. Lipp<strong>in</strong>cott Williams & Wilk<strong>in</strong>s, Philadelphia,<br />
PA, 2001, pp. 1181–1200.<br />
17. Bhas<strong>in</strong> S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle<br />
size <strong>and</strong> strength <strong>in</strong> normal men. N Engl J Med 1996;335:1–7.<br />
18. Bhas<strong>in</strong> S, Woodhouse L, Casaburi R, et al. Testosterone dose–response relationships <strong>in</strong> healthy young<br />
men. Am J Physiol Endocr<strong>in</strong>ol Metab 2001;281:E1172–E1181.<br />
19. Buena F, Swerdloff RS, Ste<strong>in</strong>er BS, et al. Sexual function does not change when serum testosterone<br />
levels are pharmacologically varied with<strong>in</strong> the normal male range. Fertil Steril 1993;59:1118–1123.<br />
20. S<strong>in</strong>gh AB, Hsia S, Alaupovic P, et al. The effects of vary<strong>in</strong>g doses of T on <strong>in</strong>sul<strong>in</strong> sensitivity, plasma<br />
lipids, apolipoprote<strong>in</strong>s, <strong>and</strong> C-reactive prote<strong>in</strong> <strong>in</strong> healthy young men. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab<br />
2002;87:136–143.<br />
21. Nank<strong>in</strong> HR. Hormone k<strong>in</strong>etics after <strong>in</strong>tramuscular testosterone cypionate. Fertil Steril 1987;47:1004–1009.<br />
22. Snyder PJ, Lawrence DA. Treatment of male hypogonadism with testosterone enanthate. J Cl<strong>in</strong><br />
Endocr<strong>in</strong>ol Metab 1980;51:1335–1339.<br />
23. Swerdloff RS, Wang C, Cunn<strong>in</strong>gham G, et al. Long-term pharmacok<strong>in</strong>etics of transdermal testosterone<br />
gel <strong>in</strong> hypogonadal men. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 2000;85:4500–4510.<br />
24. Gooren LJ. A ten-year safety study of the oral <strong>and</strong>rogen testosterone undecanoate. J Androl 1994;15:<br />
212–215.<br />
25. Wang C, Alex<strong>and</strong>er G, Berman N, et al. Testosterone replacement therapy improves mood <strong>in</strong><br />
hypogonadal men—a cl<strong>in</strong>ical research center study. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 1996;81:3578–3583.<br />
26. Wang C, Eyre DR, Clark R, et al. Subl<strong>in</strong>gual testosterone replacement improves muscle mass <strong>and</strong><br />
strength, decreases bone resorption, <strong>and</strong> <strong>in</strong>creases bone formation markers <strong>in</strong> hypogonadal men—a<br />
cl<strong>in</strong>ical research center study. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 1996;81:3654–3662.